MSLN and melanoma: Liu et al.’s study showed UBE2C inhibited the growth of melanoma cells via deactivating ERK/Akt signaling pathways and blocked G2/M transition through the downregulation of both the level and the activity of the mitosis-promoting factor (MPF), triggering the apoptosis of melanoma cells [8,17].